Vicor (VICR) VP Davies sells 3,073 shares after exercising stock options
Rhea-AI Filing Summary
Vicor Corp director and corporate VP of Global Sales & Marketing Philip D. Davies exercised stock options and sold shares of common stock. On July 1, 2026, he exercised options for 3,073 shares at exercise prices of $30.98 and $41.61 per share, then sold 3,073 shares in multiple open-market transactions at prices ranging from about $348.43 to $366.68.
The filing shows this as an exercise-and-sell pattern under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025. After these transactions, Davies holds 1,920 Vicor common shares directly and 14,679 non-qualified stock options, which continue to vest and expire on the schedules disclosed.
Positive
- None.
Negative
- None.
Insights
Routine option exercise-and-sell under a pre-planned 10b5-1 trading plan.
Philip D. Davies of Vicor Corp exercised non-qualified stock options for 3,073 shares at strike prices of $30.98 and $41.61, then sold 3,073 shares in open-market trades between roughly $348.43 and $366.68. This converts option value into cash.
The activity occurs under a Rule 10b5-1 trading plan adopted on November 21, 2025, indicating the trades were pre-scheduled rather than opportunistic. Following these transactions, he still holds 1,920 common shares and 14,679 stock options, suggesting a remaining equity stake and ongoing exposure to Vicor’s share price.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 679 | $0.00 | -- |
| Exercise | Non Qualified Stock Option | 2,394 | $0.00 | -- |
| Exercise | Common Stock | 679 | $41.61 | $28K |
| Exercise | Common Stock | 2,394 | $30.98 | $74K |
| Sale | Common Stock | 173 | $348.8351 | $60K |
| Sale | Common Stock | 200 | $349.52 | $70K |
| Sale | Common Stock | 300 | $352.45 | $106K |
| Sale | Common Stock | 300 | $353.3133 | $106K |
| Sale | Common Stock | 400 | $354.7575 | $142K |
| Sale | Common Stock | 400 | $357.62 | $143K |
| Sale | Common Stock | 300 | $358.6233 | $108K |
| Sale | Common Stock | 230 | $359.8196 | $83K |
| Sale | Common Stock | 470 | $361.9549 | $170K |
| Sale | Common Stock | 200 | $364.515 | $73K |
| Sale | Common Stock | 100 | $366.68 | $37K |
Footnotes (1)
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.4300 to $349.3900. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.4900 to $349.5500. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.2000 to $352.7300. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.2200 to $353.3600. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.4800 to $355.3300. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.2200 to $357.9800. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.4300 to $358.7400. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.4500 to $360.3000. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.5000 to $362.3000. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.3400 to $364.6900 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.6800 to $366.6800 Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on May 2, 2023 and vest over a five year period. Options expire two years from each vest date. Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on September 6, 2019 and vest over a five year period.